Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Irish Examiner, 21 june 2021
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.
CheManager, 20 October 2020
Commitment to partnership and joint innovation for cell and gene therapies
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Effective May 1st, 2020